Berardinelli-Seip Syndrome - A Case Report

1. Garg A, Agarwal AK. Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta. 2009;1791(6):507–3.10.1016/j.bbalip.2008.12.014Search in Google Scholar

2. Nolis T. Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies. J Hum Genet. 2014;59(1):16-23.10.1038/jhg.2013.107Search in Google Scholar

3. Abate N. Adipocyte maturation arrest: a determinant of systemic insulin resistance to glucose disposal. J Clin Endocrinol Metab. 2012;97(3):760–3.10.1210/jc.2012-1140Search in Google Scholar

4. Bertrand AT, Chikhaoui K, Ben Yaou R, Bonne G. [Laminopathies: one gene, several diseases]. Biol Aujourdhui. 2011;205(3):147–62.10.1051/jbio/2011017Search in Google Scholar

5. Bissonnette B, Luginbuehl I, Marciniak B, Dalens B. Syndromes: rapid recognition and perioperative imlications. New York: McGraw-Hill; 2006.Search in Google Scholar

6. Magre J, Delepine M, Khallouf E, Gedde-Dahl T Jr, Van Maldergem L, Sobel E, et al. Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 2001;28(4):365–70.10.1038/ng585Search in Google Scholar

7. Magre J, Delepine M, Van Maldergem L, Robert JJ, Maassen JA, Meiser M, et al. Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes. 2003;52(6):1573–8.10.2337/diabetes.52.6.1573Search in Google Scholar

8. Agarwal AK, Simha V, Oral EA, Moran SA, Gorden P, O’Rahilly S, et al. Phenotypic and genetic heterogenecity in congenital generalized lipodystrophy. J Clin Endocrinol Metab. 2003;88(10):4840–7.10.1210/jc.2003-030855Search in Google Scholar

9. Berardinelli W. An undiagnosed endocrinometabolic syndrome: report of 2 cases. J Clin Endocrinol Metab. 1954;14(2):3390-4.10.1210/jcem-14-2-193Search in Google Scholar

10. Seip M. Lipodystrophy and gigantism with associated endocrine manifestations: a new diencephalic syndrome? Acta Pediatr. 1959;48:555-74.Search in Google Scholar

11. Van Maldergem L, Magre J, Khallouf TE, Gedde-Dahl T Jr, Delepine M, Trygstad O, et al. Genotype–phenotype relationships in Berardinelli–Seip congenital lipodystrophy. J Med Genet. 2002;39(10):722–33.10.1136/jmg.39.10.722Search in Google Scholar

12. Roth DE, Schikler KN, Callen JP. Annular atrophic connective tissue panniculitis of the ankles. J Am Acad Dermatol. 1989;21(5 Pt 2):1152-6.10.1016/S0190-9622(89)70321-2Search in Google Scholar

13. Bennett T, Allford M. Delayed emergence from anesthesia in a child with congenital generalized lipodystrophy (Berardinelli-Seip syndrome). Paediatr Anaesth. 2012;22(3):298-313.10.1111/j.1460-9592.2011.03740.x22272673Search in Google Scholar

14. Pardini VC, Victoria IM, Rocha SM, Andrade DG, Rocha AM, Pieroni FB, et al. Leptin levels, beta-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes. J Clin Endocrinol Metab. 1998;83(2):503–8.Search in Google Scholar

15. Moran SA, Patten N, Young JR, Cochran E, Sebring N, Reynolds J, et al. Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy. Metabolism. 2004;53(4):513-9.10.1016/j.metabol.2003.10.01915045701Search in Google Scholar

16. Gorden P, Gavrilova O. The clinical uses of leptin. Curr Opin Pharmacol. 2003;3(6):655-9.10.1016/j.coph.2003.06.00614644019Search in Google Scholar